Letters, Testimony & Comments

Given by Russell M. Medford, MD, PhD President and CEO, Salutria Pharmaceuticals, LLC BIO Board Standing Committee on Bioethics Co-...
November 16 2011
July 7, 2009 Jerry Moore NIH Regulations Officer NIH, Office of Management Assessment 6011 Executive Boulevard, Suite 601, MSC 7669...
July 7 2009
Re: Draft National Institutes of Health Guidelines for Human Stem Cell Research (FR Doc. E9-9313) Dear Sir/Madam: The Biotechnology...
May 27 2009
June 6th, 2007 The Honorable Nancy Pelosi Office of the Speaker H-232, US Capitol Washington, DC 20515 Dear Speaker Pelosi: As...
June 6 2007
April 10th, 2007 The Honorable Harry Reid Majority Leader United States Senate Washington, DC 20510 Dear MR. Leader: As...
April 10 2007
Supporting the Genetic Information Nondiscrimination Act (GINA)
February 7 2006
Dear Governor Doyle: On behalf of the Biotechnology Industry Organization (BIO) and the Wisconsin Biotechnology and Medical Device...
October 3 2005
Testimony of the Biotechnology Industry Organization (BIO) Before the Texas House of Representatives State Affairs Committee Regarding...
April 11 2005
The Biotechnology Industry Organization (“BIO”) is pleased to have the opportunity to comment on the Food and Drug...
March 27 2005
Testimony of the Biotechnology Industry Organization (BIO) Before the Maryland House Health and Government Operations Committee...
March 3 2005
Testimony of the Biotechnology Industry Organization (BIO) Before the Maryland Senate Education, Health and Environmental Affairs...
March 2 2005
To the Members of the U.N. General Assembly: The Biotechnology Industry Organization (BIO) represents more than 1,000 biotechnology...
November 16 2004
Dear Sir/Madam: The following comments are provided by the Biotechnology Industry Organization (BIO). BIO represents more than 1,000...
September 27 2004
Statement of Michael J. Werner, Esq. Vice President, Bioethics Biotechnology Industry Organization Before the President's Council...
June 12 2003
Supporting legislation that prohibits genetic discrimination.
May 19 2003
Leon R. Kass, M.D., Chairman The President's Council on Bioethics 1801 Pennsylvania Avenue, NW Suite 800 Washington, DC 20005...
April 15 2003
Dear Majority Leader Daschle:      The Biotechnology Industry Organization (BIO) opposes Senator Brownback...
June 14 2002
Dear Senator Hatch:      I read in the Washington Post that Senators are considering a two-year moratorium on...
June 14 2002
Robinsue Frohboese, Ph.D. Acting Director, Office for Civil Rights U.S. Department of Health and Human Services Attention: Privacy 2,...
April 25 2002
Good morning, Mr. Chairman and Members of the Committee. My name is Dr. Charles Johnson. I am Associate Director of Specialty...
April 23 2002
Written Statement of J. Craig Venter, PhD, President, Celera Genomics On Behalf of The Biotechnology Industry Organization (BIO) Before...
July 11 2001
Good afternoon. My name is Thomas Okarma. I am the President and CEO of Geron Corporation in Menlo Park, California. Geron is a...
June 20 2001
Good afternoon. My name is Thomas Okarma. I am the President and CEO of Geron Corporation in Menlo Park, California. Geron is a...
June 19 2001
Good afternoon. My name is Carl Feldbaum. I am the president of the Biotechnology Industry Organization, otherwise known as BIO. BIO...
May 2 2001
The Biotechnology Industry Organization (BIO) is pleased to submit comments to the Food and Drug Administration (FDA) on the proposed...
April 18 2001
The Biotechnology Industry Organization (BIO) is pleased to submit comments to the Food and Drug Administration (FDA) on the proposed...
April 18 2001
Summary of Testimony of Thomas Okarma, MD, PhD BIO opposes human reproductive cloning. It is too dangerous technically and raises too...
March 30 2001
Dear Mr. President: Recently certain groups have announced plans to clone human beings. The Biotechnology Industry Organization (BIO)...
February 1 2001
President-Elect George W. Bush Bush-Cheney Transition Headquarters 1800 G Street, N.W. Washington, DC 20270 Dear President-Elect...
January 17 2001
The Biotechnology Industry Organization (BIO) submits these comments on the proposal published by the National Institutes of Health (NIH...
December 12 2000
Testimony of Joanna C. Horobin, MD Executive Vice President For Commercial Development EntreMed Inc. on behalf of Biotechnology...
April 26 2000
Good afternoon. My name is Michael Werner. I am bioethics counsel for the Biotechnology Industry Organization (BIO). BIO represents more...
March 10 2000
Dear Dr. Hamburg: The Biotechnology Industry Organization ("BIO") is pleased to offer the following comments regarding...
February 15 2000
Good morning. I am Stewart Parker, CEO of Targeted Genetics Corporation, a biotechnology company based in Seattle, Washington. I am...
February 2 2000
Dear Dr. McCabe: The Biotechnology Industry Organization (BIO) represents 850 companies, academic institutions and state biotechnology...
January 31 2000
The Biotechnology Industry Organization (BIO) is encouraged that the Subcommittee on Health and the Environment of the House Commerce...
May 27 1999
Harold Shapiro, Ph.D. Chairman c/o E. Randolph Hull National Bioethics Advisory Commission 6100 Executive Blvd., Suite 5B01...
March 22 1999
EXECUTIVE SUMMARY Pluripotent stem cells research provides the hope of a new generation of therapeutics. Using cell transplants...
January 12 1999
March 27, 1997 The Honorable William J. Clinton President of the United States The White House Washington, D.C. 20500 Dear Mr....
March 27 1997
Dear Mr. Chairman: On behalf of the Biotechnology Industry Organization (BIO), I am writing to encourage you to consider the very...
November 20 2013
BIO welcomes the opportunity to provide the views of its members on facilitating access to genetic resources and traditional knowledge and the sharing of benefits from their use...
November 16 2011
Recent reports have raised concerns about how clinical trials are being performed in other countries, particularly in the developing world...
July 7 2009
 BIO thanks the National Institutes of Health (NIH) for the opportunity to submit comments on the advanced notice of proposed rulemaking regarding conflict of interest in federally funded medical research, published in the Federal Register on May 8, 2009...
May 27 2009
The Biotechnology Industry Organization (BIO) thanks the National Institutes of Health (NIH) for the opportunity to submit comments on the draft guidelines for human stem cell research, published in the Federal Register on April 23, 2009...
June 6 2007
As President & CEO of the Biotechnology Industry Organization (BIO), I am writing to express BIO’s support for S. 5, the Stem Cell Research Enhancement Act...
November 17 2011
A timely and consistent regulatory process will ultimately result in medical treatments and cures for some of the most devastating and life-threatening diseases... 
December 16 2010
Research and development in synthetic biology is an evolution of biotechnology innovation that should be supported and encouraged by federal regulatory policies... 
September 29 2010
BIO President and CEO Jim Greenwood released the following statement on action by the U.S. Circuit Court of Appeals last night to stay the lower court’s injunction on federally funded embryonic stem cell research...
August 24 2010
BIO President and CEO Jim Greenwood issued the following statement today regarding the injunction issued yesterday by a U.S. District Court prohibiting the use of federal funds to support embryonic stem cell research...
May 24 2010
Achievement of a milestone in creating synthetic life in the form of a self-replicating cell from synthesized DNA has focused attention on the field of synthetic biology...